James E. Crowe
Impact in
- Infectious Diseases top 0.02%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
- Epidemiology top 0.05%
- Respiratory viral infections research
- Influenza Virus Research Studies
Papers in
-
- Viral Infections and Vectors 88
- Viral gastroenteritis research and epidemiology 86
- Viral Infections and Outbreaks Research 69
- SARS-CoV-2 and COVID-19 Research 58
- Epidemiology 223
- Respiratory viral infections research 142
- Influenza Virus Research Studies 54
- Co-authors
- John V. Williams (28 shared papers)Michael Diamond (32 shared papers)Brian R. Murphy (17 shared papers)Jens C. Krause (14 shared papers)Nurgun Kose (53 shared papers)Kathryn M. Edwards (19 shared papers)Peter F. Wright (11 shared papers)Sharon J. Tollefson (11 shared papers)
- Journals
- Journal of Virology (44 papers)The Journal of Infectious Diseases (26 papers)Cell Reports (19 papers)Cell Host & Microbe (18 papers)Proceedings of the National Academy of Sciences (17 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
James E. Crowe
487 papers receiving 27.8k citations
James E. Crowe's Hit Papers
Peers
Comparison fields: 5 of 185
- Infectious Diseases 14.6k
- Epidemiology 11.2k
- Virology 1.4k
- Immunology 5.0k
- Radiology, Nuclear Medicine and Imaging 3.5k
Countries citing papers authored by James E. Crowe
This map shows the geographic impact of James E. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Crowe more than expected).
Fields of papers citing papers by James E. Crowe
This network shows the impact of papers produced by James E. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Crowe. The network helps show where James E. Crowe may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Crowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 507 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children Hit paper breakdown → | 2004 | 801 |
| 2 | Potently neutralizing and protective human antibodies against SARS-CoV-2 Hit paper breakdown → | 2020 | 796 |
| 3 | Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition Hit paper breakdown → | 2020 | 725 |
| 4 | Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies Hit paper breakdown → | 2021 | 700 |
| 5 | Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 Hit paper breakdown → | 2020 | 562 |
| 6 | An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies Hit paper breakdown → | 2022 | 549 |
| 7 | Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus Hit paper breakdown → | 2010 | 515 |
| 8 | Proof of principle for epitope-focused vaccine design Hit paper breakdown → | 2014 | 446 |
| 9 | 2008 | 360 | |
| 10 | Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice Hit paper breakdown → | 2016 | 352 |
| 11 | 2020 | 351 | |
| 12 | 2012 | 343 | |
| 13 | Mxra8 is a receptor for multiple arthritogenic alphaviruses Hit paper breakdown → | 2018 | 318 |
| 14 | Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape Hit paper breakdown → | 2022 | 303 |
| 15 | Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein Hit paper breakdown → | 2021 | 282 |
| 16 | Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection Hit paper breakdown → | 2021 | 280 |
| 17 | 2000 | 270 | |
| 18 | 2010 | 229 | |
| 19 | 2019 | 220 | |
| 20 | 2006 | 220 |
About James E. Crowe
James E. Crowe is a scholar working on Infectious Diseases, Epidemiology, Immunology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health, having authored 507 papers that have together received 28.9k indexed citations. Recurring topics across this work include Respiratory viral infections research (142 papers), Viral Infections and Vectors (88 papers), Viral gastroenteritis research and epidemiology (86 papers), Monoclonal and Polyclonal Antibodies Research (78 papers), Mosquito-borne diseases and control (72 papers), Viral Infections and Outbreaks Research (69 papers), SARS-CoV-2 and COVID-19 Research (58 papers) and Influenza Virus Research Studies (54 papers). The work is most often cited by research in Infectious Diseases (14.6k citations), Epidemiology (11.2k citations), Virology (1.4k citations), Immunology (5.0k citations) and Radiology, Nuclear Medicine and Imaging (3.5k citations). James E. Crowe has collaborated with scholars based in United States, France and Germany. Frequent co-authors include John V. Williams, Michael Diamond, Brian R. Murphy, Jens C. Krause, Nurgun Kose, Kathryn M. Edwards, Peter F. Wright, Sharon J. Tollefson, Ian A. Wilson and Scott Alan Smith. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases, Cell Reports, Cell Host & Microbe and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.